Presentation is loading. Please wait.

Presentation is loading. Please wait.

Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial  Akira Sezai,

Similar presentations


Presentation on theme: "Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial  Akira Sezai,"— Presentation transcript:

1 Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial  Akira Sezai, MD, PhD, Kazutomo Minami, MD, PhD, Toshiko Nakai, MD, PhD, Mitsumasa Hata, MD, PhD, Isamu Yoshitake, MD, PhD, Shinji Wakui, MD, PhD, Motomi Shiono, MD, PhD, Atsushi Hirayama, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 6, Pages (June 2011) DOI: /j.jtcvs Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Disposition of the subjects: The PASCAL trial was conducted in 140 patients who underwent isolated coronary arterial bypass grafting. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Days of occurrence of Af.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Changes of blood pressure (systolic blood pressure and diastolic blood pressure [upper]) and heart rate [lower]. Systolic and diastolic blood pressure showed no significant differences between the 2 groups, but heart rate was significantly lower in the landiolol group. sBP, Systolic blood pressure; dBP, diastolic blood pressure; HR, heart rate. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Perioperative and postoperative fluid balance: Fluid balance showed no statistically significant difference between the 2 groups. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Ischemia–reperfusion injury parameters: CK-MB on postoperative day 1, troponin-I on postoperative days 1 and 3, and human heart fatty acid-binding protein on postoperative day 1 (at the time of returning to ICU) were significantly lower in the landiolol group compared with the placebo group. CK-MB, Creatine kinase isoenzyme MB; H-FABP, human heart fatty acid-binding protein. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

7 Figure 6 hs-CRP (upper) and urinary 8-hydroxydeoxyguanosine (lower). hs-CRP was significantly lower on postoperative day 3 in the landiolol group compared with the placebo group, but urinary 8-hydroxydeoxyguanosine showed no significant difference between the 2 groups. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

8 Figure 7 IL-6 (upper) and IL-8 (lower). IL-6 (on postoperative days 1 and 3) and IL-8 (on returning to ICU) were significantly lower in the landiolol group than in the placebo group. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial  Akira Sezai,"

Similar presentations


Ads by Google